Comparison of Neutralizing and Hemagglutination-Inhibiting Antibody Responses to Influenza A Virus Vaccination of Human Immunodeficiency Virus-Infected Individuals

American Society for Microbiology - Tập 5 Số 1 - Trang 114-117 - 1998
C. A. Benne1,2, Frank P. Kroon3, Martin C. Harmsen4, Luís Tavares4, C. A. Kraaijeveld4, J.C. de Jong5
1Eijkman-Winkler Laboratory of Medical Microbiology, University Hospital Utrecht,1; Regional Public Health Laboratory Groningen, Groningen,2The Netherlands
2Regional Public Health Laboratory Groningen, Groningen,2The Netherlands
3Department of Infectious Diseases, University Hospital Leiden, Leiden,3
4Eijkman-Winkler Laboratory of Medical Microbiology, University Hospital Utrecht,1
5Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment, Bilthoven,4 and

Tóm tắt

ABSTRACT A neutralization enzyme immunoassay (N-EIA) was used to determine the neutralizing serum antibody titers to influenza A/Taiwan/1/86 (H1N1) and Beijing/353/89 (H3N2) viruses after vaccination of 51 human immunodeficiency virus (HIV) type 1-infected individuals and 10 healthy noninfected controls against influenza virus infection. Overall, the N-EIA titers correlated well with the hemagglutination-inhibition (HAI) titers that were observed in the same samples in a previous study (F. P. Kroon, J. T. van Dissel, J. C. de Jong, and R. van Furth, AIDS 8:469–476,1994). The N-EIA appeared to be more sensitive than the HAI test. Significantly more fourfold or higher rises in N-EIA titer and higher mean N-EIA titers occurred in HIV-infected individuals with ≥200 CD4 + cells per μl than in those with <200 CD4 + cells per μl.

Từ khóa


Tài liệu tham khảo

10.1007/978-3-642-71272-2_1

10.1073/pnas.87.12.4485

Arden N. H. Cox N. J. Schonberger L. B. Prevention and control of influenza. Recommendations of the advisory committee on immunization practices (ACIP). Morbid. Mortal. Weekly Rep. 46 1997 6 7

10.1128/jcm.32.4.987-990.1994

Centers for Disease Control and Prevention Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41 1993 1 19

10.1001/jama.1989.03420020097023

10.1146/annurev.mi.37.100183.002525

10.1097/00002030-199708000-00010

Gottschalk A. Belyavin G. Biddle F. Glycoproteins as influenza hemagglutinin inhibitors and as cellular virus receptors Glycoproteins: their composition structure and function. Gottschalk A. 1992 1082 1096 Elsevier Science Publishing New York N.Y

Hobson D. Curry R. L. Beare A. S. Ward-Gardner A. The role of serum hemagglutination-inhibiting antibody in protection against challenge with influenza A2 and B viruses. J. Hyg. Camb. 70 1972 767 777

10.1001/jama.1987.03390150063035

Huengsberg M. Chakraverty M. P. Cooper G. Shahmanesh M. Response to influenza immunization in asymptomatic HIV infected men. Genitourin. Med. 71 1995 355 357

10.1007/978-3-642-46160-6_6

10.1097/00002030-199404000-00008

10.1001/jama.1989.03430060075029

10.7326/0003-4819-109-5-383

10.1182/blood.V86.3.1082.1082

10.1136/bmj.4.5842.701

10.1046/j.1365-2249.1996.25732.x

10.1378/chest.98.1.33

Schnittman S. M. Fauci A. S. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Adv. Intern. Med. 39 1994 305 355

10.1084/jem.182.6.1727

10.1128/jcm.30.4.996-999.1992

10.1378/chest.95.4.807

10.1084/jem.140.6.1559

10.1097/00002030-199410000-00022

Thông tin
Thông tin xuất bản

American Society for Microbiology

Tập 5 Số 1

114-117

Thông tin tác giả